These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21907251)

  • 1. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo.
    Kidd ME; Shin S; Shea LD
    J Control Release; 2012 Jan; 157(1):80-5. PubMed ID: 21907251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.
    Shin S; Shea LD
    Mol Ther; 2010 Apr; 18(4):700-6. PubMed ID: 20051940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin hydrogels for non-viral vector delivery in vitro.
    des Rieux A; Shikanov A; Shea LD
    J Control Release; 2009 Jun; 136(2):148-54. PubMed ID: 19232532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized lentivirus delivery via peptide interactions.
    Skoumal M; Seidlits S; Shin S; Shea L
    Biotechnol Bioeng; 2016 Sep; 113(9):2033-40. PubMed ID: 26913962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays.
    Raut SD; Lei P; Padmashali RM; Andreadis ST
    J Control Release; 2010 Jun; 144(2):213-20. PubMed ID: 20153386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogels for lentiviral gene delivery.
    Seidlits SK; Gower RM; Shepard JA; Shea LD
    Expert Opin Drug Deliv; 2013 Apr; 10(4):499-509. PubMed ID: 23347508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors.
    Thomas AM; Gomez AJ; Palma JL; Yap WT; Shea LD
    Biomaterials; 2014 Oct; 35(30):8687-93. PubMed ID: 25023395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis.
    Shepard JA; Virani FR; Goodman AG; Gossett TD; Shin S; Shea LD
    Biomaterials; 2012 Oct; 33(30):7412-21. PubMed ID: 22800542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poloxamine/fibrin hybrid hydrogels for non-viral gene delivery.
    Zhang J; Sen A; Cho E; Lee JS; Webb K
    J Tissue Eng Regen Med; 2017 Jan; 11(1):246-255. PubMed ID: 24889259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle.
    Stilhano RS; Madrigal JL; Wong K; Williams PA; Martin PK; Yamaguchi FS; Samoto VY; Han SW; Silva EA
    J Control Release; 2016 Sep; 237():42-9. PubMed ID: 27374631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds.
    Avilés MO; Shea LD
    Drug Deliv Transl Res; 2011 Feb; 1(1):91-101. PubMed ID: 22229129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels.
    Padmashali RM; Andreadis ST
    Biomaterials; 2011 Apr; 32(12):3330-9. PubMed ID: 21296411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.
    Thomas AM; Palma JL; Shea LD
    J Control Release; 2015 Apr; 204():1-10. PubMed ID: 25724274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-fibrin interpenetrating double network hydrogel prepared in situ by orthogonal disulfide cross-linking reaction for biomedical applications.
    Zhang Y; Heher P; Hilborn J; Redl H; Ossipov DA
    Acta Biomater; 2016 Jul; 38():23-32. PubMed ID: 27134013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
    Wieland JA; Houchin-Ray TL; Shea LD
    J Control Release; 2007 Jul; 120(3):233-41. PubMed ID: 17582640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and stability of interpenetrating polymer network hydrogels consisting of fibrin and hyaluronic acid for tissue engineering.
    Lee F; Kurisawa M
    Acta Biomater; 2013 Feb; 9(2):5143-52. PubMed ID: 22943886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-fibrin hydrogels show improved mechanical stability in dermo-epidermal skin substitutes.
    Montero A; Atienza C; Elvira C; Jorcano JL; Velasco D
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112352. PubMed ID: 34474900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non viral vector delivery in vitro using fibrin hydrogels.
    Park K
    J Control Release; 2009 Jun; 136(2):87. PubMed ID: 19383520
    [No Abstract]   [Full Text] [Related]  

  • 19. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy.
    Schek RM; Hollister SJ; Krebsbach PH
    Mol Ther; 2004 Jan; 9(1):130-8. PubMed ID: 14741786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic fibrin-hyaluronan hydrogels for nucleus pulposus regeneration.
    Li Z; Kaplan KM; Wertzel A; Peroglio M; Amit B; Alini M; Grad S; Yayon A
    Regen Med; 2014 May; 9(3):309-26. PubMed ID: 24935043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.